Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

SELL
$67.33 - $77.71 $27.4 Million - $31.6 Million
-406,399 Reduced 98.55%
6,000 $462,000
Q1 2024

Apr 10, 2024

BUY
$57.6 - $68.62 $144,000 - $171,550
2,500 Added 0.61%
412,399 $28.2 Million
Q4 2023

Jan 19, 2024

BUY
$48.64 - $57.81 $30,400 - $36,131
625 Added 0.15%
409,899 $23.7 Million
Q3 2023

Oct 11, 2023

SELL
$50.19 - $54.68 $104,144 - $113,461
-2,075 Reduced 0.5%
409,274 $21.6 Million
Q2 2023

Jul 07, 2023

BUY
$49.72 - $54.64 $154,877 - $170,203
3,115 Added 0.76%
411,349 $22.2 Million
Q1 2023

Apr 04, 2023

SELL
$45.09 - $50.03 $112,725 - $125,075
-2,500 Reduced 0.61%
408,234 $20.4 Million
Q4 2022

Jan 09, 2023

BUY
$39.56 - $47.22 $19,780 - $23,610
500 Added 0.12%
410,734 $19 Million
Q3 2022

Oct 07, 2022

BUY
$36.71 - $109.66 $223,931 - $668,926
6,100 Added 1.51%
410,234 $15.9 Million
Q2 2022

Jul 06, 2022

BUY
$35.24 - $47.1 $126,864 - $169,560
3,600 Added 0.9%
404,134 $15.1 Million
Q1 2022

Apr 08, 2022

BUY
$40.9 - $45.1 $241,310 - $266,090
5,900 Added 1.5%
400,534 $17.7 Million
Q4 2021

Jan 13, 2022

SELL
$38.07 - $44.87 $354,051 - $417,291
-9,300 Reduced 2.3%
394,634 $16.8 Million
Q3 2021

Oct 07, 2021

SELL
$41.23 - $45.88 $5,813 - $6,469
-141 Reduced 0.03%
403,934 $17.5 Million
Q2 2021

Jul 13, 2021

BUY
$38.58 - $44.24 $100,308 - $115,024
2,600 Added 0.65%
404,075 $17.3 Million
Q1 2021

Apr 09, 2021

BUY
$35.27 - $39.67 $5,290 - $5,950
150 Added 0.04%
401,475 $15.5 Million
Q4 2020

Jan 11, 2021

BUY
$33.15 - $41.97 $1.63 Million - $2.06 Million
49,175 Added 13.96%
401,325 $13.9 Million
Q3 2020

Oct 05, 2020

BUY
$34.44 - $42.23 $12.1 Million - $14.9 Million
352,150 New
352,150 $13.5 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $146B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Nexus Investment Management Ulc Portfolio

Follow Nexus Investment Management Ulc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nexus Investment Management Ulc, based on Form 13F filings with the SEC.

News

Stay updated on Nexus Investment Management Ulc with notifications on news.